Table 3.
Recommended antihypertensive medication class use among hypertensive patients with compelling indications
| Antihypertensive therapies indicated for compelling indications | With Compelling Indication + Indicated Therapy | Without Compelling Indication + Indicated Therapy | p-value | |
|---|---|---|---|---|
| Compelling Indication | Indicated Therapy Regimen | % | % | |
| Diabetes | Percentage of patients with HTN+DM prescribed ACEI/ARB | 78.3% | 60.8% | <0.001 |
| Heart failure | Percentage of patients with HTN+HF prescribed ACEI/ARB or BB | 88.7% | 80.3% | <0.001 |
| Post-MI | Percentage of patients with HTN+MI prescribed ACEI/ARB or BB | 88.3% | 80.5% | <0.02 |
| Chronic kidney disease (CKD) | Percentage of patients with HTN+CKD prescribed ACEI/ARB | 67.7% | 65.1% | ns |
| Post-stroke | Percentage of patients with HTN+stroke-TIA-carotid stenosis prescribed thiazide diuretic and ACEI | 14.6% | 13.7% | ns |